Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 16 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.96 Insider Own22.06% Shs Outstand18.05M Perf Week20.49%
Market Cap132.67M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float14.07M Perf Month45.83%
Income-16.78M PEG- EPS next Q-0.26 Inst Own9.37% Short Float1.83% Perf Quarter47.00%
Sales44.38M P/S2.99 EPS this Y9.69% Inst Trans30.18% Short Ratio8.71 Perf Half Y68.19%
Book/sh2.74 P/B2.69 EPS next Y- ROA-18.69% Short Interest0.26M Perf Year-9.93%
Cash/sh0.29 P/C25.13 EPS next 5Y- ROE-29.70% 52W Range4.05 - 9.94 Perf YTD62.61%
Dividend Est.- P/FCF- EPS past 5Y-47.90% ROI-24.69% 52W High-26.07% Beta-0.30
Dividend TTM- Quick Ratio2.10 Sales past 5Y91.63% Gross Margin36.59% 52W Low81.48% ATR (14)0.46
Dividend Ex-DateMay 24, 2022 Current Ratio2.28 EPS Y/Y TTM-179.97% Oper. Margin-48.70% RSI (14)68.66 Volatility9.51% 7.58%
Employees113 Debt/Eq0.43 Sales Y/Y TTM-63.81% Profit Margin-37.81% Recom1.00 Target Price11.00
Option/ShortYes / Yes LT Debt/Eq0.38 EPS Q/Q-221.40% Payout- Rel Volume7.06 Prev Close6.16
Sales Surprise-59.40% EPS Surprise-96.15% Sales Q/Q-83.97% EarningsMar 15 BMO Avg Volume29.53K Price7.35
SMA2018.33% SMA5035.07% SMA20039.81% Trades Volume190,036 Change19.42%
Date Action Analyst Rating Change Price Target Change
Dec-20-21Initiated H.C. Wainwright Buy $12
Oct-13-21Downgrade Dawson James Buy → Neutral
Jan-20-21Initiated Dawson James Buy $25
Apr-16-24 08:00AM
Apr-10-24 08:00AM
Apr-01-24 09:00PM
Mar-18-24 09:20AM
12:53PM Loading…
Mar-15-24 12:53PM
Mar-08-24 08:00AM
Feb-21-24 08:00AM
Feb-20-24 08:00AM
Feb-14-24 08:00AM
Feb-08-24 08:00AM
Jan-30-24 08:00AM
Jan-23-24 08:00AM
Jan-04-24 08:00AM
01:50PM Loading…
Nov-10-23 01:50PM
Nov-09-23 09:25AM
Nov-02-23 08:00AM
Oct-17-23 08:00AM
Oct-12-23 08:25AM
Aug-10-23 10:40AM
Aug-03-23 08:00AM
Aug-02-23 08:00AM
Jun-29-23 08:00AM
Jun-22-23 08:30AM
Jun-09-23 08:00AM
08:00AM Loading…
Jun-07-23 08:00AM
Jun-01-23 08:30AM
May-11-23 09:35AM
May-08-23 08:30AM
May-04-23 08:30AM
May-03-23 08:30AM
May-01-23 08:00AM
Apr-28-23 08:30AM
Apr-27-23 06:36PM
Apr-25-23 08:30AM
Apr-24-23 09:00AM
Apr-18-23 08:00AM
Apr-10-23 03:20AM
Mar-31-23 06:37AM
Mar-30-23 08:27AM
Mar-28-23 09:35AM
Mar-21-23 08:00AM
Mar-15-23 08:00AM
Mar-13-23 08:00AM
Mar-10-23 06:52PM
Mar-07-23 08:00AM
Mar-01-23 08:00AM
Feb-22-23 08:00AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-06-23 08:00AM
Jan-19-23 05:55AM
Jan-05-23 08:00AM
Dec-19-22 08:30AM
Dec-15-22 09:12AM
Dec-05-22 08:30AM
Nov-30-22 08:00AM
Nov-12-22 07:43AM
Nov-10-22 09:35AM
Nov-08-22 08:00AM
Nov-07-22 07:12PM
Nov-04-22 08:00AM
Nov-01-22 09:40AM
Oct-19-22 08:00AM
Oct-18-22 12:19PM
Oct-17-22 08:00AM
Sep-28-22 07:17AM
Sep-27-22 08:11AM
Sep-08-22 09:40AM
Sep-06-22 08:15AM
Aug-25-22 01:45PM
Aug-23-22 09:40AM
Aug-11-22 09:25AM
Aug-04-22 08:33PM
Aug-02-22 06:15PM
Jul-28-22 03:24PM
Jul-26-22 08:00AM
Jul-21-22 06:00PM
Jul-19-22 08:30AM
Jul-18-22 07:38AM
Jul-12-22 06:30AM
Jul-11-22 06:25AM
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.